ClearSight NextGen1 Study
NCT07317648
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Blood Pressure
Interventions
DEVICE:
ClearSight NextGen system
Sponsor
Edwards Lifesciences